8-K current report · filed May 6, 2026

Core Scientific, Inc./tx (CORZ) 8-K Current Report: May 6, 2026

Item 1.01Item 1.02Item 2.03Item 8.01CORZ overviewOriginal on SEC EDGAR

Short answer

Core Scientific, Inc./tx (CORZ) filed an 8-K current report with the SEC on May 6, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 1.02 (Termination of a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation), Item 8.01 (Other Events). $3.3B senior secured notes issued at 7.750% due May 15, 2031, creating substantial long-term financing obligations.

Core Scientific, Inc./tx 8-K event analysis

AI summary of each reported item and its exhibits

Item 1.01 · Entry into a Material Definitive Agreement

  • $3.3B senior secured notes issued at 7.750% due May 15, 2031, creating substantial long-term financing obligations
  • Approximately $3.24B net proceeds, including debt service reserves and repayment of Core Scientific’s Bridge Facility
  • First-priority liens cover substantially all Issuer and guarantor assets, increasing creditor claims on operating assets
  • Semiannual principal amortization begins after the first installment date at an initial annual rate of 11.50%
  • Uncapped completion guarantee exposes Core Scientific to funding shortfalls for projects, though it does not guarantee the notes directly

Item 1.02 · Termination of a Material Definitive Agreement

  • Core Scientific repaid all borrowings under the $1,000.0 million senior secured Bridge Facility
  • Repayment funded by proceeds from issuing and selling Notes
  • Bridge Credit Agreement liabilities, obligations, and indebtedness fully released on May 6, 2026
  • Replaces short-term bridge financing with Notes, potentially extending funding duration and changing debt costs

Item 8.01 · Other Events

  • Core Scientific announced pricing of a securities offering on April 22, 2026
  • Offering proceeds’ intended use may affect liquidity, capital investment, and shareholder dilution
  • Investors must review Exhibit 99.1 for offering size, security type, pricing, and proceeds allocation
  • Forward-looking proceeds plans remain subject to execution risks and may differ materially from expectations

Other items in this filing:

  • Item 2.03: Creation of a Direct Financial Obligation

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Core Scientific, Inc./tx 8-K filings

Get the next CORZ 8-K as it lands

Follow CORZ for push alerts, or ask the research agent what this filing means.